title: Hemophagocytic lymphohistiocytosis syndrome in Dengue hemorrhagic fever.
abstract: Hemophagocytic lymphohistiocytosis (HLH) is a life threatening florid activation of macrophages of the lymphoreticular system. It is reported to be associated with dengue in children in India and carries a high mortality. Patients present with high fever, worsening blood cell counts, splenomegaly, abnormal liver enzymes with features of liver failure, coagulopathy and neurological complications. The diagnosis is according to "Diagnostic Guidelines for HLH 2004", based on a triad of clinical, blood parameters and bone marrow cytology. In the present study, data of 212 children admitted with dengue were analyzed. Of 212 children, 31 children were classified as suspect HLH and advised bone marrow evaluation; of whom 23 children had marrow evidence of HLH. Worsening of blood cell counts were recorded in all children with a mean platelet count of 58,303.03 cells/cumm, low hematocrit in 95.65 %, low mean hemoglobin level of 8.37 g/dL, high erythrocyte sedimentation rate (ESR) and prolonged pro-thrombin time/international normalization ratio (PT/INR). Serum triglycerides, ferritin and transaminases were high. Of the 23 children, 19 patients received intravenous immunoglobulin (IVIG) and all of these children recovered. Dengue with multi-organ dysfunction is commonly concurrent to HLH in the marrow and hence, an early diagnosis based on clinical, laboratory and bone marrow evaluation is significant. A bone marrow evaluation confirms the diagnosis of HLH.
authors.affiliation: Department of Pediatrics, Krishna Hospitals, Tirunelveli, Tamilnadu, India.
authors.forename: S
authors.initials: S
authors.lastname: Raju
authors.forename: Shantaraman
authors.initials: S
authors.lastname: Kalyanaraman
authors.forename: K
authors.initials: K
authors.lastname: Swaminathan
authors.forename: A
authors.initials: A
authors.lastname: Nisha
authors.forename: S
authors.initials: S
authors.lastname: Praisid
mesh_terms: D001853:Bone Marrow; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007194:India; D007223:Infant; D051359:Lymphohistiocytosis, Hemophagocytic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D019595:Severe Dengue / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D008775:Methylprednisolone
references.citation: Dev Med Child Neurol. 2001 Aug;43(8):555-8
references.pmid: 11508922
references.citation: Indian Pediatr. 2011 Jan;48(1):31-5
references.pmid: 20972297
references.citation: Postgrad Med J. 2013 Apr;89(1050):185-92
references.pmid: 23243150
references.citation: J Glob Infect Dis. 2011 Oct;3(4):399-401
references.pmid: 22224008
references.citation: Rev Med Interne. 2002 Sep;23(9):768-78
references.pmid: 12378830
references.citation: Pediatr Blood Cancer. 2007 Feb;48(2):124-31
references.pmid: 16937360
references.citation: J Med Assoc Thai. 2008 Jan;91(1):104-9
references.pmid: 18386553
references.citation: Indian J Pediatr. 2006 May;73(5):445-6
references.pmid: 16741336
references.citation: Br J Haematol. 2001 Sep;114(4):761-9
references.pmid: 11564062
references.citation: Indian J Pediatr. 2010 Dec;77(12):1434-6
references.pmid: 20931303